Delhi HC orders patent office to decide Ribociclib
Change
The Delhi High Court ordered the Controller General of Patents to decide Novartis's Ribociclib patent application and oppositions and to frame an SOP with timeline-bound disposal, within four months.
Why it matters
The Controller General must draft a standard operating procedure that sets disposal timelines for patent applications. The directive specifically covers the Novartis Ribociclib application and oppositions filed against it. The Controller is required to decide the application and oppositions within four months. Timely disposal of patent applications must be prioritized and timelines adhered to.
Implications
- • Patent-office leadership must implement and enforce a new SOP that assigns firm timelines for case disposal.
- • Examiners will face mandated prioritization and compressed scheduling to meet the four-month decision window for the Ribociclib matter.
Unlock the decision layer.
See what the change means — implications, exposure, timing — and ask AI about any brief instantly.
- Implications: What actually changes downstream.
- Who is affected: Which teams or operators are exposed.
- What to watch: Deadlines, triggers, and next moves.
- Ask AI: Clarify any brief instantly, in context.
14-day free trial. Full access. No credit card required.
Start free trial
Source
Topics